Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7764-7773

  Blohmke, Christoph J ^a   Victor, Rachel E ^a   Hirschfeld, Aaron F ^a   Elias, Isaac M ^a   Hancock, David G ^a   Lane, Cheryl R ^a   Davidson, A George F ^a   Wilcox, Pearce G ^b   Smith, Kelly D ^d   Overhage, Joerg ^c   Hancock, Robert E W ^c   Turvey, Stuart E ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR 5; FLAGELLIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD CELL; BURKHOLDERIA CEPACIA; CELL MOTILITY; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INNATE IMMUNITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; DRUG ANTAGONISM; EPITHELIUM CELL; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL;

BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; EPITHELIAL CELLS; FLAGELLIN; HUMANS; IMMUNITY, NATURAL; LEUKOCYTES, MONONUCLEAR; LUNG; PSEUDOMONAS AERUGINOSA; TOLL-LIKE RECEPTOR 5;

EID: 47249131603     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7764     Document Type: Article

References (51)

1. Raljen, F., and G. Doling. 2003. Cystic fibrosis. Lancet 361: 681-689.
2. Chmiel, J. F., and M. W. Konstan. 2007. Inflammation and anti-inflammatory therapies for cystic fibrosis. Clin. Chest Med. 28: 331-346.
3. Aucrbach, H. S., M. Williams, J. A. Kirkpatrick, and H. R. Colten. 1985. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 2: 686-688.
4. Konstan, M. W., P. J. Byard, C. L. Hoppel, and P. B. Davis. 1995. Effect of high-dose ibuprofen in patients with cystic fibrosis. N. Engl. J. Med. 332: 848-854.
5. Ratjen, F. 2006. What's new in CF airway inflammation: an update. Paediatr. Respir. Rev. 7: S70-S72.
6. Machen, T. E. 2006. Innate immune response in CF airway epithelia: hyperin-flammatory? Am. J. Physiol. 291: C218-C230.
7. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
8. Muir, A., G. Soong, S. Sokol, B. Reddy, M. I. Gomez, A. Van Heeckeren, and A. Prince. 2004. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 30: 777-783.
9. Greene, C. M., T. P. Carroll, S. G. Smith, C. C. Taggart, J. Devaney, S. Griffin, S. J. O'Neill, and N. G. McElvaney. 2005. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J. Immunol. 174: 1638-1646.
10. Khan, T. Z., J. S. Wagener, T. Bost, J. Martinez, F. J. Accurso, and D. W. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am, J. Respir. Crit. Care Med. 151: 1075-1082.
11. Noah, T. L., H. R. Black, P. W. Cheng, R. E. Wood, and M. W. Leigh. 1997. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J. Infect. Dis. 175: 638-647.
12. Erridge, C, A. Pridmore, A. Eley, J. Stewart, and I. R. Poxton. 2004. Lipopoly-saccharides of Bacleroides fragilis, Chlamydia trachomatis, and Pseudomonas aeruginosa signal via Toll-like receptor 2. J. Med. Microbiol. 53: 735-740.
13. Epelman, S., D. Stack, C. Bell, E. Wong, G. G. Neely, S. Krutzik, K. Miyake, P. Kubes, L. D. Zbytnuik, L. L. Ma, et al. 2004. Different domains of Pseudomonas aeruginosa exoenzyme S activate distinct TLRs. J. Immunol. 173: 2031-2040.
14. Adamo, R., S. Sokol, G. Soong, M. I. Gomez, and A. Prince. 2004. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM 1 and Toll-like receptor 2 as well as Toll-like receptor 5. Am. J. Respir. Cell Mol. Biol. 30: 627-634.
15. Flotte, T. R., S. A. Afione, R. Solow, M. L. Drumm, D. Markakis, W. B. Guggino, P. L. Zeitlin, and B. J. Carter. 1993. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268: 3781-3790.
16. Hirschfeld, A. F., J. A. Bettinger, R. E. Victor, D. J. Davidson, A. J. Currie, J. M. Ansermino, D. W. Scheifele, J. S. Orange, and S. E. Turvey. 2007. Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection. Clin. Immunol. 122: 271-278.
17. West, S. E., H. P. Schweizer, C. Dall, A. K. Sample, and L. J. Runyen-Janecky. 1994. Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. Gene 148: 81-86.
18. Smith, K. D., E. Andersen-Nissen, F. Hayashi, K. Strobe, M. A. Bergman, S. L. Barrett, B. T. Cookson, and A. Aderem. 2003. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 4: 1247-1253.
19. Mahenthiralingam, E., M. E. Campbell, and D. P. Speert. 1994. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 62: 596-605.
20. Chen, J. H., H. Schulman, and P. Gardner. 1989. A cAMP-regulated chloride channel in lymphocytes that is affected in-cystic fibrosis. Science 243: 657-660.
21. Di, A., M. E. Brown, L. V. Deriy, C. Li, F. L. Szeto, Y. Chen, P. Huang, J. Tong, A. P. Naren, V. Bindokas, et al. 2006. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat. Cell. Biol. 8: 933-944.
22. Gomez, M. I., A. Lee, B. Reddy, A. Muir, G. Soong, A. Pitt, A. Cheung, and A. Prince. 2004. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat. Med. 10: 842-848.
23. Homung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537.
24. Miao, E. A., E. Andersen-Nissen, S. E. Warren, and A. Aderem. 2007. TLRS and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin. Immunopathol. 29: 275-288.
25. Vij, N., M. O. Amoako, S. Mazur, and P. L. Zeitlin. 2008. CHOP transcription factor mediates IL-8 signaling in cystic fibrosis bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 38: 176-184.
26. Borgatti, M., V. Bezzerri, I. Mahcini, E. Nicolis, M. C. Dechecchi, I. Lampronti, P. Rizzotti, G. Cabrini, and R. Gambari. 2007. Induction of IL-6 gene expression in a CF bronchial epithelial cell line by Pseudomonas aeruginosa is dependent on transcription factors belonging to the Spl superfamily. Biochem. Biophys. Res. Commun. 357: 977-983.
27. Muselet-Charlier, C, T. Roque, E. Boncoeur, K. Chadelat, A. Clement, J. Jacquot, and O. Tabary. 2007. Enhanced IL-lβ-induced IL-8 production in cystic fibrosis lung epithelial cells is dependent of both mitogen-activated protein kinases and NF-κB signaling. Biochem. Biophys. Res. Commun. 357: 402-407.
28. Power, M. R., Y. Peng, E. Maydanski, J. S. Marshall, and T. J. Lin. 2004. The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J. Biol. Chem. 279: 49315-49322.
29. Tseng, J., J. Do, J. H. Widdicombe, and T. E. Machen. 2006. Innate immune responses of human tracheal epithelium to Pseudomonas aeruginosa flagellin, TNF-α, and IL-1β. Am. J. Physiol. 290: C678-C690.
30. Jia, H. P., J. N. Kline, A. Penisten, M. A. Apicella, T. L. Gioannini, J. Weiss, and P. B. McCray, Jr. 2004. Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. Am. J. Physiol. 287: L428-L437.
31. Becker, M. N., G. Diamond, M. W. Verghese, and S. H. Randell. 2000. CD14-dependent lipopolysaccharide-induced β-defensin-2 expression in human tra-cheobronchial epithelium. J. Biol. Chem. 275: 29731-29736.
32. Ramphal, R., V. Balloy, M. Huerre, M. Si-Tahar, and M. Chignard. 2005. TLRs 2 and 4 are not involved in hypersusceptibility to acute Pseudomonas aeruginosa lung infections. J. Immunol. 175: 3927-3934.
33. Feuillet, V., S. Medjane, I. Mondor, O. Demaria, P. P. Pagni, J. E. Galan, R. A. Flavell, and L. Alexopoulou. 2006. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc. Natl. Acad. Sci. USA 103: 12487-12492.
34. Goss, C. H., and J. L. Burns. 2007. Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax 62: 360-367.
35. Sadikot, R. T., T. S. Blackwell, J. W. Christman, and A. S. Prince. 2005. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171: 1209-1223.
36. Hybiske, K., J. K. Ichikawa, V. Huang, S. J. Lory, and T. E. Machen. 2004. Cystic fibrosis airway epithelial cell polarity and bacterial flagellin determine host response to Pseudomonas aeruginosa. Cell. Microbiol. 6: 49-63.
37. Skerrett, S. J., C. B. Wilson, H. D. Liggitt, and A. M. Hajjar. 2007. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am. J. Physiol. 292: L312-L322.
38. Zhang, Z., J. P. Louboutin. D. J. Weiner, J. B. Goldberg, and J. M. Wilson. 2005. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect. Immun. 73: 7151-7160.
39. Hawn, T. R., A. Verbon, K. D. Lettinga, L. P. Zhao, S. S. Li, R. J. Laws, S. J. Skerrett, B. Beutler, L. Schroeder, A. Nachman, et al. 2003. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease. J. Exp. Med. 198: 1563-1572.
40. Dunstan, S. J., T. R. Hawn, N. T. Hue, C. P. Parry, V. A. Ho, H. Vinh, T. S. Diep, D. House, J. Wain, A. Aderem, et al. 2005. Host susceptibility and clinical outcomes in Toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J. Infect. Dis. 191: 1068-1071.
41. Balloy, V., A. Verma, S. Kuravi, M. Si-Tahar, M. Chignard, and R. Ramphal. 2007. The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa. J. Infect. Dis. 196: 289-296.
42. Wolfgang, M. C., J. Jyot, A. L. Goodman, R. Ramphal, and S. Lory. 2004. Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 101: 6664-6668.
43. Arora, S. K., A. N. Neely, B. Blair, S. Lory, and R. Ramphal. 2005. Role of motility and flagellin glycosylation in the pathogenesis of Pseudomonas aeruginosa bum wound infections. Infect. Immun. 73: 4395-4398.
44. Mayer-Hamblett, N., M. L. Aitken, F. J. Accurso, R. A. Kronmal, M. W. Konstan, J. L. Burns, S. D. Sagel, and B. W. Ramsey. 2007. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 175: 822-828.
45. Sonawane, A., J. Jyot, R. During, and R. Ramphal. 2006. Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa. Infect. Immun. 74: 6682-6689.
46. Jyot, J., A. Sonawane, W. Wu, and R. Ramphal. 2007. Genetic mechanisms involved in the repression of flagellar assembly by Pseudomonas aeruginosa in human mucus. Mol. Microbiol. 63: 1026-1038.
47. Simpson, D. A., R. Ramphal, and S. Lory. 1992. Genetic analysis of Pseudomonas aeruginosa adherence: distinct genetic loci control attachment to epithelial cells and mucins. Infect. Immun. 60: 3771-3779.
48. Hancock, R. E., and A. M. Carey. 1979. Outer membrane of Pseudomonas aeruginosa: heat-2-mercaptoethanol-modifiable proteins. J. Bacteriol. 140: 902-910.
49. Kropinski, A. M., L. C. Chan, and F. H. Milazzo. 1979. The extraction and analysis of lipopolysaccharides from Pseudomonas aeruginosa strain PAO, and three rough mutants. Can. J. Microbiol. 25: 390-398.
50. Jarrell, K. F., and A. M. Kropinski. 1981. Isolation and characterization of a bacteriophage specific for the Iipopolysaccharide of rough derivatives of Pseudomonas aeruginosa strain PAO. J. Virol. 38: 529-538.
51. Lewenza, S., R. K. Falsafi, G. Winsor, W. J. Gooderham, J. B. McPhee, F. S. Brinkman,.and R. E. Hancock. 2005. Construction of a mini-Tn5-luxCD-ABE mutant library in Pseudomonas aeruginosa PAO1: a tool for identifying differentially regulated genes. Genome Res. 15: 583-589.